Rehab Program for Spinal Stenosis
Trial Summary
What is the purpose of this trial?
The aim of this study is to determine the effectiveness of a 6-week specific rehabilitation program combining education and exercises on walking capacity in patients with LSS causing NC. The intervention group will receive standardized education and specific exercises while the control group will only receive standardized education. The program in both groups will last for 6 weeks with 4 evaluation timepoints (baseline, week 2, week 4 and post-intervention assessment). The primary outcomes will be walking capacity measured with the Self-Paced Walking Test and the secondary outcomes will be back and leg pain intensity, LSS-related disability, self-efficacy, level of physical activity, anxiety and depression, physical activity level, gait pattern characteristics, balance, and global perceived change.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Specific Rehabilitation Program for spinal stenosis?
Research shows that a 6-week specific rehabilitation program combining education and exercises can improve walking capacity in patients with lumbar spinal stenosis, which is a common cause of disability. This suggests that targeted rehabilitation programs may help improve mobility and quality of life for those with this condition.12345
Is the rehab program for spinal stenosis safe for humans?
Research on spinal stenosis treatments, including surgery, shows a low risk of complications, with a 3.5 per 1000 operations fatality rate within 30 days. Non-surgical treatments, like lifestyle interventions and balance exercises, have been studied for safety and feasibility, suggesting they are generally safe for humans.678910
How is the Specific Rehabilitation Program treatment different from other treatments for spinal stenosis?
Eligibility Criteria
This trial is for people over 50 with lumbar spinal stenosis (LSS) causing nerve compression, who can speak French and commit to three sessions a week. They should be able to walk 20 meters but not continuously for 30 minutes. Excluded are those with congenital LSS, significant hip/knee arthritis, neurological diseases like Parkinson's, uncontrolled diabetes, heart failure, vascular claudication or recent back surgery.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-week specific rehabilitation program combining education and exercises
Follow-up
Participants are monitored for changes in anxiety, depression, physical activity, and other secondary outcomes
Treatment Details
Interventions
- Specific Rehabilitation Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université du Québec à Trois-Rivières
Lead Sponsor